Skip to content

Observation on the Efficacy of Half a Box of Ramitine Combined with One Bottle of Simethicone in Bowel Preparation Prior to Capsule Endoscopy

Observation on the Efficacy of Half a Box of Ramitine Combined with One Bottle of Simethicone in Bowel Preparation Prior to Capsule Endoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126990
Enrollment
Unknown
Registered
2026-06-22
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of different bowel preparation strategies on diagnosis in patients scheduled for small bowel capsule endoscopy.

Interventions

Patients undergoing small intestine capsule endoscopy:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18-70 years, no gender restriction, with suspected small bowel disease requiring capsule endoscopy; 2.Patients in generally good condition, without contraindications such as severe cardiac, hepatic, or renal insufficiency, gastrointestinal bleeding, or intestinal obstruction; 3.Patients without a history of gastrointestinal surgery or gastrointestinal metal implants; 4.Patients who have signed the informed consent form for the clinical study;

Exclusion criteria

Exclusion criteria: 1.Patients in poor general condition with contraindications such as severe cardiac, hepatic, or renal insufficiency, gastrointestinal bleeding, or intestinal obstruction; 2.Patients with unstable mental status who are unable to cooperate; 3.Patients with a history of gastrointestinal surgery or gastrointestinal metal implants;

Design outcomes

Primary

MeasureTime frame
Intestinal cleanliness score;Patient tolerance and satisfaction;

Countries

China

Contacts

Public ContactHe Weimei

Huzhou Center Hospital

heweimei1030@163.com+86 572 8465021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026